<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04787822</url>
  </required_header>
  <id_info>
    <org_study_id>834898</org_study_id>
    <secondary_id>U01HL145435</secondary_id>
    <nct_id>NCT04787822</nct_id>
  </id_info>
  <brief_title>Long Term Follow up of the LTOG Cohort</brief_title>
  <acronym>LTOG</acronym>
  <official_title>Long Term Follow up of the Lung Transplant Outcomes Group Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to follow participants who enrolled in the Lung Transplant&#xD;
      Outcomes Group. Clinical data, functional assessments, and surveys will be collected to&#xD;
      determine long term graft function and functional status of lung transplant recipients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This project will involve both retrospective and prospective data collection from&#xD;
      participants enrolled in the LTOG cohort studies. We will perform long-term Chronic Lung&#xD;
      Allograft Dysfunction (CLAD) phenotyping of lung transplant recipients who participated in&#xD;
      the LTOG cohort studies utilizing data collected for routine clinical visits. Surviving lung&#xD;
      transplant recipients who participated in the LTOG cohort studies will be recruited to enroll&#xD;
      in the longitudinal portion of the project. The longitudinal component will include follow-up&#xD;
      data collection at 6 month intervals while alive until study termination, study withdrawal,&#xD;
      or no longer being seen for follow-up at the participating center. Follow-up data collection&#xD;
      will include clinical data collected by study coordinators by reviewing medical records,&#xD;
      functional assessment through administration of the Short Physical Performance Battery&#xD;
      (SPPB), blood collection and surveys. Data from this project will be linked to data and&#xD;
      samples collected during the LTOG cohort or ancillary studies.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2021</start_date>
  <completion_date type="Anticipated">May 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Chronic Lung Allograft Dysfunction (CLAD) phenotyping</measure>
    <time_frame>From date of transplant to the development of CLAD, up to 25 years</time_frame>
    <description>Change in pulmonary function measured by serial pulmonary function tests (PFTs) and data collected at clinical care visits will be used to assess CLAD.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional status phenotyping</measure>
    <time_frame>From date of transplant to until study termination, withdrawal, or no longer being seen for follow-up at the participating center, up to 25 years</time_frame>
    <description>Change in functional status will be measured by the Short Physical Performance Battery (SPPB). The SPPB is a 3-construct measure that includes gait speed, chair stands, and balance. Each construct is scored from 0 - 4 yielding an aggregate score ranging from 0 - 12. Lower SPPB scores reflect increased frailty.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Well being phenotyping-LT-VLA</measure>
    <time_frame>From date of transplant to until study termination, withdrawal, or no longer being seen for follow-up at the participating center, up to 25 years</time_frame>
    <description>Change in well being will be measured by patient reported outcomes including the LT-VLA scale. The LT-VLA scale presents a list of activities and asks respondents to rate their difficulty in performing each one on a 4-point scale. A higher score on the LT-VLA indicates more disability.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Well being phenotyping-LT-QOL</measure>
    <time_frame>From date of transplant to until study termination, withdrawal, or no longer being seen for follow-up at the participating center, up to 25 years</time_frame>
    <description>Change in well being will be measured by patient reported outcomes including the Lung Transplant Quality of Life (LT-QOL) survey. The Lung Transplant Quality of Life (LT-QOL) survey will be used to measure disease specific QOL. The LT-QOL utilizes 5 point scales for all items. The general quality of life scale is scored so that higher scores indicate better QOL.</description>
  </primary_outcome>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Lung Transplant Failure and Rejection</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma and buffy coat&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Lung transplant recipients who have previously enrolled in the LTOG cohort studies at one&#xD;
        of the participating centers.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria&#xD;
&#xD;
        Long-term phenotyping of CLAD&#xD;
&#xD;
          -  Lung transplant recipients who have previously enrolled in the LTOG cohort studies at&#xD;
             one of the participating centers&#xD;
&#xD;
        Long-term functional status and well-being&#xD;
&#xD;
          -  Lung transplant recipients who have previously enrolled in the LTOG cohort studies at&#xD;
             one of the participating centers&#xD;
&#xD;
          -  Alive&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
        Long-term phenotyping of CLAD&#xD;
&#xD;
          -  Lung transplant recipient not enrolled in LTOG cohort research studies&#xD;
&#xD;
        Long-term functional status and well-being&#xD;
&#xD;
          -  Lung transplant recipient not enrolled in the LTOG cohort research studies&#xD;
&#xD;
          -  Lung transplant recipient not receiving post-transplant follow-up care at a&#xD;
             participating LTOG center&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason Christie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Scott Palmer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jason Christie, MD</last_name>
    <phone>215-662-6003</phone>
    <email>jason.christie@pennmedicine.upenn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michelle Oyster, MS</last_name>
    <phone>215-573-4767</phone>
    <email>oysterm@pennmedicine.upenn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Renita Holmes</last_name>
      <email>rlholmes@uabmc.edu</email>
    </contact>
    <investigator>
      <last_name>Keith Willie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gayelan Tietje-Ulrich</last_name>
      <phone>415-476-4539</phone>
      <email>Gayelan.Tietje-Ulrich@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Jonathan Singer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gowri Vasudevan</last_name>
      <phone>650-736-8083</phone>
      <email>gowriv@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Ann Weinacker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean Nash, RN</last_name>
      <phone>317-962-0485</phone>
      <email>JNash3@IUHealth.org</email>
    </contact>
    <investigator>
      <last_name>Chadi Hage, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joby Mathew</last_name>
      <email>jmathe27@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Pali Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mary Maliarik, PhD</last_name>
      <phone>734-615-8627</phone>
      <email>marymali@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Vibha Lama</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shreena Patel, LPN</last_name>
      <phone>212-305-5527</phone>
      <email>sp3646@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Luke Benvenuto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Courtney Frankel</last_name>
      <email>courtney.frankel@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Laurie Snyder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Oyster, MS</last_name>
      <phone>215-573-4767</phone>
      <email>oysterm@pennmedicine.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Jason D. Christie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joshua M. Diamond, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ritchie Koshy, MD</last_name>
      <phone>412-802-8624</phone>
      <email>koshyrg@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>John McDyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>February 22, 2021</study_first_submitted>
  <study_first_submitted_qc>March 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2021</study_first_posted>
  <last_update_submitted>June 15, 2021</last_update_submitted>
  <last_update_submitted_qc>June 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic lung allograft dysfunction</keyword>
  <keyword>Functional status</keyword>
  <keyword>Lung transplantation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

